White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation

Journal of Nutrition

Volumn 131, Issue 12, 2001, Pages 3288-3293

  Grube, B J ^a   Eng, E T ^a   Kao, Y C ^a   Kwon, A ^a   Chen, S ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Aromatase; Breast cancer; Diet and cancer prevention; White button mushrooms

Indexed keywords

AGARICUS BISPORUS EXTRACT; AROMATASE; ESTROGEN; FLAVONE; ISOFLAVONE; UNCLASSIFIED DRUG;

AGARICUS BISPORUS; ARTICLE; ASSAY; BREAST CARCINOGENESIS; CANCER CELL; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ESTROGEN SYNTHESIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROSOME; MUSHROOM; POSTMENOPAUSE; THERMOSTABILITY;

AGARICUS BISPORUS; BASIDIOMYCOTA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0035205521     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/131.12.3288     Document Type: Article

References (50)

1. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer
2. The importance of local synthesis of estrogen within the breast
3. Detection of intrtumoral aromatase in breast carcinomas
4. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders
5. Stromal spindle cells contain aromatase in human breast tumors
6. Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction (RT-PCR)
7. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers
8. Aromatase in the normal breast and breast cancer
9. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities
10. In situ aromatization enhances breast tumor estrdiol levels and cellular proliferation
11. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
12. The potential of aromatase inhibitors in breast cancer prevention
13. New non-steroidal aromatase inhibitors: Focus on R76713
14. Arimidex (ZD1033): A selective, potent inhibitor of aromatase in postmenopausal female volunteers
15. Chemopreventive effects of the aromatase inhibitors vorozole (R-83843) and 4-hydroxyandrostenedione in the methlnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats
16. Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model
17. Development of breast cancer chemopreventive drugs
18. Vegetables, fruit and phytoestrogens as preventive agents
19. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer
20. Intake of fruits and vegetables and risk of breast cancer: A pooled analysis of cohort studies
21. Metaanalysis of studies on breast cancer risk and diet: The role of fruit and vegetable consumption and the intake of associated micronutrients
22. Breast cancer: Magnitude of the problem and descriptive epidemiology
23. Dietary effects on breast-cancer risk in Singapore
24. Soy isoflavonoids and cancer prevention
25. Inhibition of human aromatase by mammalian lignans and isolavonoid phytoestrogens
26. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes
27. Aromatase inhibition by flavonoids
28. Inhibition of estrogen synthetase (aromatase) by flavones
29. Effects of flavonoids on aromatase activity, an in vitro study
30. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes
31. Binding characteristics of seven aromatase inhibitors to human aromatase. A site-directed mutagenesis study
32. Binding characteristics of aromatase inhibitors and pytoestrogens to human aromatase
33. Molecular basis of the inhibition of human aromatase by flavone and isoflavone phytoestrogens. A site-directed mutagenesis study
34. Suppression of breast cancer cell growth with grape juice
35. Purification of water soluble natural products
36. Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn, and Asp309Ala, and their interactions with aromatase inhibitors
37. Purification of human placental aromatase cytochrome P-450 with monoclonal antibody and its characterization
38. Stable expression of human aromatase cDNA in mammalian cells - A useful system for aromatase inhibitor screening
39. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione
40. An induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women
41. Interaction of flavones and their bromoacetyl derivatives with NAD(P)H: Quinone acceptor oxidoreductase
42. Autocrine and paracrine actions of breast aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells
43. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
44. Chemoprevention of breast cancer
45. Comparison of serum carotenoid responses between women consuming vegetable juice and women consuming raw or cooked vegetables
46. Screening of potential cancer preventing chemicals as aromatase inhibitors in an in vitro assay
47. Functional properties of edible mushrooms
48. Antitumor activity of aqueous extracts of edible mushrooms
49. Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments
50. Structure function studies of human aromatase